...
首页> 外文期刊>Patient Preference and Adherence >Assessing Oral Medication Adherence and Identifying Predictors of Low Adherence in Chinese Inflammatory Bowel Disease Patients
【24h】

Assessing Oral Medication Adherence and Identifying Predictors of Low Adherence in Chinese Inflammatory Bowel Disease Patients

机译:评估口服药物遵守和识别中国炎症性肠病患者低粘附的预测因子

获取原文
           

摘要

Background: Poor medication adherence in inflammatory bowel disease (IBD) had a negative impact on disease outcomes. In this study, we aimed to determine predictors of low adherence in the Chinese IBD populations and also aimed to compare a self-reported scale to a pharmacy refill index in assessing adherence of 5-ASA and azathioprine taken by Chinese IBD patients. Patients and Methods: Adult patients with IBD who had been taking 5-ASA or azathioprine for at least 3 months were recruited from hospital outpatient clinics. The MPR was calculated from previous six-month pharmacy refill data and the self-reported Morisky Medication Adherence Scale (MMAS-8) was issued through QR code questionnaires. Intentional and unintentional adherence scores were calculated according to specific items. Non-adherence was defined as MMAS-8 scores 6 or MPR 0.8. Results: The response rate in the IBD patients was as high as 97%. 5-ASA non-adherence rate assessed by MPR was 30% and 37% by MMAS-8, and azathioprine non-adherence rate assessed was 33% by both MPR and MMAS-8. In a linear regression analysis, MPR value was significantly correlated with MMAS-8 score in 5-ASA group (r=0.4, p=0.003), and significantly correlated with unintentional adherence score (r=0.47, p 0.001). No significant correlation was observed between MPR value and MMAS-8 score in azathioprine group. Multivariate analysis demonstrated that age (OR: 1.08; 95% CI: 1.02– 1.13; P=0.0015) and previous abdominal surgery (OR: 3.18; 95% CI: 2.09– 4.27; P=0.04) were associated with high medication adherence. While patients who had small intestine lesion (OR: 0.09; 95% CI: 0.01– 0.17; P=0.006) were associated with low adherence. Conclusion: Predictors of low adherence were young age, lesions on small intestine, whereas previous abdominal surgery was a protective factor. This study also demonstrated that the MMAS-8 scale was a valid instrument for assessing 5-ASA adherence in IBD patients. Unintentional non-adherence was significantly related to the total non-adherence, which would allow to use the tool to seek ways for adherence improvement.
机译:背景:炎症性肠病(IBD)对疾病结果的差的药物粘附性不良。在这项研究中,我们旨在确定中国IBD群体中低依从性的预测因素,并旨在将自我报告的规模与评估中国IBD患者采取的5-ASA和AzathInline的粘附性进行比较。患者及方法:从医院门诊诊所招募了服用5-ASA或AzathioPrine至少3个月的IBD的成年患者。 MPR由先前的六个月药房补充数据计算,通过QR码问卷发出自我报告的Morisky药物申诉规模(MMAS-8)。根据具体项目计算故意和无意的遵守评分。非依从性被定义为MMAS-8分数<6或MPR <0.8。结果:IBD患者的响应率高达97%。 MPR评估的5-ASA非粘附率为30%和37%,通过MPR和MMAS-8评估的AzathioLine非粘附率为33%。在线性回归分析中,MPR值与5-ASA组中的MMA-8得分显着相关(r = 0.4,p = 0.003),并与无意的粘附得分显着相关(r = 0.47,p <0.001)。在AzathioLine组的MPR值和MMAS-8得分之间没有观察到显着相关性。多变量分析表明,年龄(或:1.08; 95%CI:1.02- 1.13; p = 0.0015)和之前的腹部手术(或:3.18; 95%CI:2.09- 4.27; p = 0.04)与高药物遵守有关。患有小肠病变的患者(或:0.09; 95%CI:0.01- 0.17; p = 0.006)与低粘附相关。结论:低粘附的预测因子是年轻的年龄,小肠病变,而之前的腹部手术是一种保护因素。本研究还证明了MMAS-8规模是用于评估IBD患者5-ASA粘附的有效仪器。无意的非遵守与总不遵守的总相关关系显着相关,这将允许使用该工具寻求依从性改善的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号